Morgan Stanley has published a research report on Allergan Inc. AGN in anticipation of the company's Botox bladder expert call scheduled for March 22nd.
In the report, Morgan Stanley writes "We are hosting Dr. Michael Chancellor at 9AM on Tuesday, March 22, to discuss the first Phase III data on Botox in overactive neurogenic bladder (866- 953-0764, password: 546 698 34). Data will be presented on Sunday, March 20 at EAU in Vienna. Dr. Chancellor is a Professor of Urology, Obstetric-Gynecology, and McGowan Institute of Regenerative Medicine at the University Of Pittsburgh School Of Medicine."
Morgan Stanley maintains its Overweight rating on Allergan, which closed yesterday at $68.90.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
